Avinger Inc. has received CE Mark approval for Pantheris – a system that combines directional atherectomy capabilities with real-time intravascular visualization to remove plaque from blocked arteries. Pantheris is designed to remove the blockage while avoiding the disruption of normal arterial wall structures. This new type of image-guided atherectomy is referred to as lumectomy. Currently, approximately 200 million patients worldwide suffer from peripheral artery disease (PAD).

 

Ascendian Healthcare Consulting has announced a comprehensive vendor neutral archive (VNA) acceleration solution that enables healthcare organizations rapid accessibility, efficiency and shared utilization of medical imaging assets. 

August 30, 2013 — PFM Medical received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its Nit-Occlud Patent Ductus Arteriosus (PDA) device, a permanently implanted prosthesis indicated for percutaneous, transcatheter closure of small to moderate size patent ductus arteriosus.

By Dave Fornell, DAIC Editor
 
There are two main issues facing clinical practice today, including lower reimbursements and the need to see more patients, which combined calls for technology that can improve efficiency and increased patient throughput. In addition, there are inherent issues with traditional 2-D ultrasound imaging technology, including that the quality of image acquisition relies on the skill and experience of the operator.

Philips Healthcare launched the Epiq ultrasound system, a first-of-its-kind ultrasound architecture that offers a new approach to creating ultrasound images. Making its debut at the European Society of Cardiology (ESC) 2013 Congress in Amsterdam, Epiq features a new imaging technology called nSIGHT that, when combined with Philips' new Anatomical Intelligence technology, delivers faster speed and improved image clarity. It has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Diagnosing Pericardial Disease Using Multi-modality Imaging Protocols

To counter the significant levels of morbidity and mortality associated with pericardial disease (disease of the sac around the heart), experts from the American Society of Echocardiography (ASE), the Society for Cardiovascular Magnetic Resonance (SCMR), and the Society of Cardiovascular Computed Tomography (SCCT) came together to review evidence and provide future guidance to clinicians. For the first time, an expert consensus statement on the appropriate use of multimodality imaging in the diagnosis and management of pericardial diseases will be published in the September issue of the Journal of the American Society of Echocardiography (JASE). The writing group was chaired by Allan L. Klein, M.D., FASE, director of Cardiovascular Imaging Research and the Pericardial Center and an echocardiographer from the esteemed Cleveland Clinic in Cleveland, Ohio.

 

Digirad Corp. and Dilon Diagnostics have signed an exclusive international distribution agreement for Dilon to distribute Digirad's lines of nuclear imaging cameras. . 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now